Showing results (11-20 of 27) with videos related to

Sort By:
Pageof 3
Blood|March 3, 2011
Down-regulation of stathmin expression is required for megakaryocyte maturation and platelet productionCamelia Iancu-Rubin, David Gajzer, Joseph Tripodi, et al.
Blood|August 9, 2012
Combination treatment in vitro with Nutlin, a small-molecule antagonist of MDM2, and pegylated interferon-α 2a specifically targets JAK2V617F-positive polycythemia vera cellsMin Lu, Xiaoli Wang, Yan Li, et al.
Head & Neck|November 30, 2016
Reappraising hyalinizing clear cell carcinoma: A population-based study with molecular confirmationJuan C Hernandez-Prera, Ricky Kwan, Joseph Tripodi, et al.
Acta Haematologica|May 8, 2019
A Novel t(1;9)(p36;p24.1) JAK2 Translocation and Review of the LiteratureHannah Levavi, Joseph Tripodi, Bridget Marcellino, et al.
Blood Advances|December 20, 2018
Advanced forms of MPNs are accompanied by chromosomal abnormalities that lead to dysregulation of TP53Bridget K Marcellino, Ronald Hoffman, Joseph Tripodi, et al.
Blood|September 7, 2014
JAK2 inhibitors do not affect stem cells present in the spleens of patients with myelofibrosisXiaoli Wang, Fei Ye, Joseph Tripodi, et al.
Leukemia|December 23, 2024
HMGA2 overexpression with specific chromosomal abnormalities predominate in CALR and ASXL1 mutated myelofibrosisShivani Handa, Christoph Schaniel, Joseph Tripodi, et al.
Scientific Reports|February 17, 2015
Double minute amplification of mutant PDGF receptor α in a mouse glioma modelHongyan Zou, Rui Feng, Yong Huang, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 22, 2019
Multipotent fetal-derived Cdx2 cells from placenta regenerate the heartSangeetha Vadakke-Madathil, Gina LaRocca, Koen Raedschelders, et al.
The Journal of Clinical Investigation|October 2, 2012
Spleens of myelofibrosis patients contain malignant hematopoietic stem cellsXiaoli Wang, Sonam Prakash, Min Lu, et al.
Pageof 3